Track topics on Twitter Track topics that are important to you
From genes to leads
Axxam is a science-driven biotechnology company focused on early-stage discovery research and services for the life science industry.
Our from genes to leads activities include target biology, assay development, high-throughput screening (HTS) and compound profiling.
The strategic combination of our scientific know-how and extensive experience in drug discovery aims to maintain our leadership role as a profitable provider of discovery services, products and technologies. Above all, we strive to be a premier discovery partner for biopharmaceutical companies.
A team of more than 60 qualified personnel is committed to the advancement of the discovery research of our pharmaceutical, biotechnology and agrochemical partners. The scientific know-how of our team is built upon years of experience as part of the assay development group of the Bayer HealthCare, Research and Development organization prior to the late 2001 inauguration of Axxam as an independent private company.
The growing list of our industry collaborations in the biopharmaceutical industry and beyond is recognition of the expanding market opportunities available to us to apply our technologies in areas such as the agrochemical industry and fragrance and flavor manufacturers.
Biomedical Science Park via Olgettina 58
Phone: 39 02 210561
Fax: 39 02 210560
A research collaboration between Axxam and Sanofi has been announced, which will be aimed at further optimising several small molecules targeted against a range of diseases of the central nervous syst...
French pharmaceutical company Sanofi and Italian biotech firm Axxam have entered a new research collaboration in the field of neurodegenerative disorders.
Italian biotech firm Axxam has announced the start of a research collaboration with French pharma major…
Life Sciences Jobs ...
Sanofi has entered a research agreement with drug discovery services provider Axxam.
Try as we might, we can’t cover all the biotech news out there! Here’s a roundup of news that didn’t make the cut this week. Italian outfit Axxam has found a partner in Sanofi for its efforts i...
SummaryAxxam SpA Axxam is a partner research organization that provides drug discovery services. The organization offers drug discovery services such as molecular biology, assay development and reagen...
AACHEN, Germany, July 7, 2017 /PRNewswire/ -- The new research project NGN-PET was launched in the framework of the Innovative Medicine Initiative (IMI), the largest public-private partnership ...
From genes to leadsAxxam is a science-driven biotechnology company focused on early-stage discovery research and services for the life science industry. Our from genes to leads activities include targ...
We have published hundreds of Axxam news stories on BioPortfolio along with dozens of Axxam Clinical Trials and PubMed Articles about Axxam for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Axxam Companies in our database. You can also find out about relevant Axxam Drugs and Medications on this site too.
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity. This can be a drug or biochemical substance or a cell in an organism or organic sample. ...